19/09/2014 03:53:35 Free Membership Login

   

Alexion Pharmaceuticals, Inc.

Visual Financials
Company Name: Alexion Pharmaceuticals, Inc.
Ticker Symbol: ALXN
WWW Address: http://www.alexionpharm.com
CEO: Leonard Bell
No. of Employees: 1,373
Common Issue Type: CS
Business Description:Alexion Pharmaceuticals, Inc. is a biopharmaceutical company engaged in serving patients with severe and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 161.61 Up 0.08 157.06 162.85 161.83 163.42 160.45 621081
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 31,968.9 197.8 0.00 1.29 0.00 129.4 0.0 185.43 - 100.89
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close161.57$
PE Ratio - LTM129.4
Market Capitalisation31,968.9mil
Latest Shares Outstanding197.8mil
Earnings pS (EPS)1.29$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee874,490$
Effective Tax Rate0.5%
Float153.6mil
Float as % of Shares Outstanding0.8%
Foreign Sales990mil
Domestic Sales561mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.30%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin88.6%
EBITDA Margin36.0%
Pre-Tax Profit Margin33.9%
Assets Turnover52.3%
Return on Assets (ROA)8.5%
Return on Equity (ROE)11.6%
Return on Capital Invested (ROCI)11.0%
Current Ratio3.8
Leverage Ratio (Assets/Equity)1.4
Interest Cover129.0
Total Debt/Equity (Gearing Ratio)0.06
LT Debt/Total Capital4.0%
Working Capital pS8.11$
Cash pS0.00$
Book-Value pS14.57$
Tangible Book-Value pS7.68$
Cash Flow pS2.13$
Free Cash Flow pS1.75$
KEY FIGURES (LTM): Price info
Price/Book Ratio11.17
Price/Tangible Book Ratio0.00
Price/Cash Flow76.3
Price/Free Cash Flow93.5
P/E as % of Industry Group241.0%
P/E as % of Sector Segment48.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----3.2-4919,1723,538,489
4 Weeks172.96157.29166.47-3.0-4839,64316,792,871
13 Weeks175.00154.38159.691.2-11,129,55572,291,561
26 Weeks177.20136.37173.66-7.0-141,353,583171,905,157
52 Weeks185.43100.89114.0341.7251,313,283330,947,392
YTD185.43126.76-21.1111,422,678256,082,217
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
161.93163.31164.37162.84156.890.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.430.80.42
Income0.500.50.38
Dividend0.0
Capital Spending0.56NA0.46
R&D28.58NA38.53
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %38.538.544.8
Earnings %81.081.045.4
EPS %78.378.340.7
EPS $0.180.180.37
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio48.36
Current Ratio3.8
Quick Ratio (Acid Test)3.3
Liquidity Ratio (Cash)3.51
Receivables Turnover4.3
Average Collection Period84
Working Capital/Equity67.4
Working Capital pS8.11
Cash-Flow pS2.49
Free Cash-Flow pS2.34
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio22.36
Financial Leverage Ratio (Assets/Equity)0.1
Debt Ratio4.4
Total Debt/Equity (Gearing Ratio)0.06
LT Debt/Equity0.04
LT Debt/Capital Invested14.2
LT Debt/Total Liabilities44.8
Interest Cover129.0
Interest/Capital Invested0.15
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio9.70
Current P/E Ratio - LTM129.40
Enterprise Value (EV)/EBITDA55.59
Enterprise Value (EV)/Free Cash Flow67.72
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM11.17
Price/Cash Flow Ratio76.3
Price/Free Cash Flow Ratio - LTM93.5
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM72.3
P/E Ratio (26 weeks ago) - LTM83.4
P/E Ratio (52 weeks ago) - LTM93.3
5-Y High P/E Ratio93.3
5-Y Low P/E Ratio10.8
5-Y Average P/E Ratio66.9
Current P/E Ratio as % of 5-Y Average P/E58
P/E as % of Industry Group241.0
P/E as % of Sector Segment48.0
Current 12 Month Normalized P/E Ratio - LTM55.1
PER SHARE FIGURES
LT Debt pS0.38
Current Liabilities pS3.40
Tangible Book Value pS - LTM7.68
Book Value pS - LTM14.57
Capital Invested pS12.61
Cash pS - LTM0.00
Cash Flow pS - LTM2.13
Free Cash Flow pS - LTM1.75
Earnings pS (EPS)1.29
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin30.17
Free Cash Flow Margin 5YEAR AVG13.94
Net Profit Margin0.2
Net Profit Margin - 5YEAR AVRG.0.3
Equity Productivity0.65
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.0.2
Capital Invested Productivity0.62
Return on Capital Invested (ROCI)0.2
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.2
Assets Productivity0.50
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.2
Gross Profit Margin88.6
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM36.0
EBIT Margin - LTM34.2
Pre-Tax Profit Margin0.3
Pre-Tax Profit Margin - 5YEAR AVRG.0.3
Effective Tax Rate0.0
Effective Tax Rate - 5YEAR AVRG.-32.0
EFFICIENCY RATIOS
Cash Conversion Cycle4,997,719
Revenue per Employee874,490
Net Income per Employee142,556
Average Collection Period4,997,719
Receivables Turnover4.3
Day's Inventory Turnover Ratio
Inventory Turnover1.8
Inventory/Sales6.6
Accounts Payble/Sales1.39
Assets/Revenue2.00
Net Working Capital Turnover0.97
Fixed Assets Turnover1.37
Total Assets Turnover0.5
Revenue per $ Cash2.93
Revenue per $ Plant7.71
Revenue per $ Common Equity0.65
Revenue per $ Capital Invested0.62
Selling, General & Adm/tive (SG&A) as % of Revenue31.6
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue20.4
R&D Expense as % of Revenue - 5YEAR AVRG.20.4

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alxn140919 03:53